Marek Rola-Pleszczynski
Overview
Explore the profile of Marek Rola-Pleszczynski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
810
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lapointe F, Turcotte S, Roy J, Bissonnette E, Rola-Pleszczynski M, Stankova J
J Cell Sci
. 2019 Nov;
133(5).
PMID: 31722979
Cysteinyl-leukotrienes (cys-LTs) have well-characterized physiopathological roles in the development of inflammatory diseases. We have previously found that protein tyrosine phosphatase ε (PTPε) is a signaling partner of CysLTR, a high...
2.
Hamel-Cote G, Lapointe F, Veronneau S, Mayhue M, Rola-Pleszczynski M, Stankova J
Cell Biosci
. 2019 Jul;
9:51.
PMID: 31289638
Background: An underlying state of inflammation is thought to be an important cause of cardiovascular disease. Among cells involved in the early steps of atherosclerosis, monocyte-derived dendritic cells (Mo-DCs) respond...
3.
Lapointe F, Turcotte S, Veronneau S, Rola-Pleszczynski M, Stankova J
J Pharmacol Exp Ther
. 2019 Mar;
369(2):270-281.
PMID: 30867226
Phosphorylation on tyrosine residues is recognized as an important mechanism for connecting extracellular stimuli to cellular events and defines a variety of physiologic responses downstream of G protein-coupled receptor (GPCR)...
4.
Hamel-Cote G, Lapointe F, Gendron D, Rola-Pleszczynski M, Stankova J
Cell Commun Signal
. 2019 Mar;
17(1):21.
PMID: 30832675
Background: Platelet-activating factor (PAF) is a potent lipid mediator whose involvement in the onset and progression of atherosclerosis is mediated by, among others, the modulation of cytokine expression patterns. The...
5.
Boudaud M, Turcotte S, Stankova J, Rola-Pleszczynski M
J Immunol
. 2018 Sep;
201(9):2787-2798.
PMID: 30242072
IL-33 and cysteinyl leukotrienes (cysLTs) are key components of asthma pathogenesis, and both contribute to the initiation and maintenance of the type 2 inflammatory environment. However, little is known about...
6.
Hamel-Cote G, Gendron D, Rola-Pleszczynski M, Stankova J
PLoS One
. 2017 Jul;
12(7):e0180336.
PMID: 28686728
Atherosclerosis is a pro-inflammatory condition underlying many cardiovascular diseases. Platelet-activating factor (PAF) and interleukin 6 (IL-6) are actively involved in the onset and progression of atherosclerotic plaques. The involvement of...
7.
Lacraz G, Rakotoarivelo V, Labbe S, Vernier M, Noll C, Mayhue M, et al.
PLoS One
. 2016 Nov;
11(11):e0166537.
PMID: 27824945
[This corrects the article DOI: 10.1371/journal.pone.0162995.].
8.
Lacraz G, Rakotoarivelo V, Labbe S, Vernier M, Noll C, Mayhue M, et al.
PLoS One
. 2016 Sep;
11(9):e0162995.
PMID: 27684068
Objective: IL-15 is an inflammatory cytokine secreted by many cell types. IL-15 is also produced during physical exercise by skeletal muscle and has been reported to reduce weight gain in...
9.
Zerif E, Maalem A, Gaudreau S, Guindi C, Ramzan M, Veroneau S, et al.
J Autoimmun
. 2016 Sep;
76:63-74.
PMID: 27634616
Defects in dendritic cells (DCs) development and function lead to autoimmune disorders. Autoimmune diabetes in humans and NOD mice results from a breakdown of self-tolerance, ending in T cell-mediated β-cell...
10.
Yaddaden L, Veronneau S, Thompson M, Rola-Pleszczynski M, Stankova J
Prostaglandins Leukot Essent Fatty Acids
. 2016 Feb;
105:1-8.
PMID: 26869085
Cysteinyl-leukotrienes are pro-inflammatory lipid mediators, involved in allergic asthma, that bind the G-protein-coupled receptors CysLT1, CysLT2 and GPR99. A polymorphism in one of these receptors, CysLT1-G300S was strongly associated with...